medicine-technology-1/nexbio-28r-29-publishes-two-articles-showing-das181--28fludase-28r-29--29-potently-inhibits-pandemic-influenza-a-28h1n1-29-and-nai-resistant-influenza-6043-2/;/a></li><li><a

Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2 Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3 Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4 Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2 Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2

[0] Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans [0] Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer [0] For Release: Esco Announces 2nd North American Facility in Marietta, OH [0] Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology

Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2 Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2 Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3 Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2 Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3 ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 1 ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 2 ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 3 ERKs got rhythm 3A Protein that controls cell growth found to cycle in and out of cell nucleus 10934 4 Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 1 Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 2 Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 3 Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 1 Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 2 Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe Finds Frost 26amp 3B Sullivan 62334 3

[0] Dynatronics Receives 180-Day NASDAQ Extension [0] Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug [0] Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign